Zdrowie i gospodarka · 15/10/1997

FDA Amends Biologics Regulations to Simplify Control and Oversight

The Food and Drug Administration (FDA) is eliminating the requirement for a 'responsible head' or 'designated qualified person' at biological manufacturing facilities, aiming to provide more flexibility for companies with complex corporate structures and multiple locations.